Proceeds to support the development of first candidates for IND-enabling studies, as well as expand discovery and RNA chemistry capabilities to address a wider set of serious liver-related diseases.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2093 Philadelphia Pike
Claymont, DE 19703
USA

Phone

Undisclosed

Website

www.ochre-bio.com

Email Address

[email protected]

Overview

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases, a top ten global killer. We uncover new biological pathways by using advances in 'deep phenotyping', and then study our medicines in human livers kept alive on machines.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jack O' Meara

Chief Scientific Officer

Quin Wills

VP - Finance

Paul Foster

Browse more venture capital transactions:

Prev: 10/10/2022: LingoAce venture capital transaction
Next: 10/10/2022: GridBeyond venture capital transaction

Share this article

News on VC Transactions

We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary